Investment Pitches

Pitch Summary:
B. Fitlife acquisition of Irwin out of bankruptcy – thousands of pages distilled in hours. Last week, Fitlife Brands announced it was acquiring Irwin Naturals out of bankruptcy , doubling the size of its business. AI allowed us to produce a comprehensive update merely ~5 hours after the transformative acquisition. First, it located the bankruptcy filings in minutes , along with various news articles and financial disclosures of Irwin that otherwise would have taken us an hour or two to locate. Second, after we had pulled a few key documents, NotebookLM analyzed these documents at our behest to tell us which of the other 700+ filings likely contained important information. It referenced a few dozen, which we then downloaded to update its data -set (imagine how much time this saved vs. clicking download on 700 documents!). NotebookLM built a chronological narrative from thousands of pages of legal text, letting us focus on the filings that truly mattered. A manual approach would have taken days, yet still missed details buried in obscure exhibits.

BSD Analysis:
FitLife is a high-margin, asset-light supplement business that leaned into direct-to-consumer, brand licensing, and acquisitive growth with more discipline than most nutraceutical peers. Cash flow is strong, margins are improving, and the portfolio strategy lets FitLife scale without building bloated infrastructure. As consumers prioritize performance, weight loss, and functional wellness, FitLife has a niche portfolio positioned for premium pricing. This is a quietly profitable microcap executing a tight playbook.

Pitch Summary:
Even if we pencil in pretty good 2026 numbers – and value the stock based on these – it appears to trade at ~13.5x EV/EBITDA and 20x EV/NOPAT, which is simply too rich for a cyclically exposed, capital-intensive hardware company. Further, a meaningful percentage of Bel’s earnings come from products that are likely to be impacted by tariffs or reshoring over time, particularly its legacy networking business. We worry that investors extrapolating recent strength in earnings into the future may be underestimating both the cyclicality of demand and the durability of competition in Bel’s end-markets. While we still view Bel as a well-run business with improved operational discipline, the risk/reward at today’s valuation no longer meets our standards. As a result, we chose to exit our position and reallocate capital into opportunities with more attractive upside relative to downside.

BSD Analysis:
Bel Fuse is a small-cap power and connectivity supplier that reinvented itself through margin discipline, mix improvement, and smarter product focus. The company now sits in mission-critical niches of networking, industrial automation, and aerospace/defense — categories with long product lifecycles and high switching costs. Bel’s operational turnaround has been impressive, and the balance sheet is now strong enough to fuel more strategic moves. This is an underfollowed tech-industrial hybrid with real structural improvements.

Pitch Summary:
Conversely, we held on to most of our Grocery Outlet (GO) stock after the 40%+ post -earnings pop, only making a modest trim, because as we continued to conduct more due diligence, including a half -dozen calls with former key leaders, we concluded that it is a special and competitively differentiated business that has suffered from a combination of excessive growth expectations (which led to a lack of focus on getting the basics right), as well as a botched ERP implementation (which caused ripple effects thr oughout the business). With new CEO Jason Potter having an excellent history of turning around grocery peer The Fresh Market (TFM) – and a refreshed Board including former Sprouts CFO Chip Molloy – the setup here reminds us a lot of Jack Sinclair’s early days at Sprouts. Given the habitual nature of grocery purchase, it takes time for operating improvements to flow through to comp growth, but there seems to be a multi -year runway for driving numerous blocking -and-tackling self -help improvements, ranging from private label penetration to better merchandising to better technology tools for stores to manage their forecasting / inventory ordering. We sold Sprouts far too soon, and don’t intend to make the same mistake here. Finally, this is a business that benefits from many of the key challenges in the world – it passes along inflation to consumers, and as an extreme -value grocer, it sees not only stable but rapidly growing demand during economic downturns (it comped somethi ng like 27% cumulatively in 2008/2009 during the GFC). Therefore, although the stock is not screamingly cheap at ~17.5x our forward estimate of NOPAT, we believe that its very stable demand profile – and a long runway of improvements – make it worth conti nuing to hold a meaningful position. Again, I want to be careful to thread the needle here; we would likel g aggressively at ~17.5x to fund purchases of vastly inferior businesses, even if those businesses trade at a meaningfully greater discount to our fair value estimate, given what we view as the very high probability that this business will achieve our expectations over the next several years.

BSD Analysis:
Grocery Outlet wins by selling quality branded goods at off-price economics — a model tailor-made for inflation-fatigued consumers. The independent operator structure gives it local flexibility with corporate buying power behind it. As mainstream supermarkets fight margin compression, Grocery Outlet thrives by turning supply-chain chaos into treasure-hunt value. Traffic is sticky, unit economics are strong, and recession risk is upside, not downside. This is a defensive consumer machine with real legs.

Pitch Summary:
Additionally, although outside the second quarter timeframe, we added Zoetis to the portfolio on July 1. Zoetis specializes in veterinary pharmaceuticals, and pet owners likely recognize many of their products. The surge in pet ownership during the pandemic has expanded the company's addressable market, as pets age and require increased medical care, driving higher healthcare costs. Zoetis offers a compelling investment case due to its stable growth trajectory, strong profit margins, and current undervaluation in a market segment that has fallen out of favor, making its shares attractively priced at levels not seen in years.

BSD Analysis:
The manager added Zoetis as a value opportunity in the out-of-favor veterinary pharmaceuticals sector. The investment thesis is built on pandemic-driven pet ownership growth expanding the addressable market as aging pets require increased medical care. This demographic shift creates a sustainable tailwind for higher veterinary healthcare spending over time. The manager highlights Zoetis's stable growth profile and strong profit margins as key fundamental strengths supporting the investment case. The timing appears opportunistic, with shares trading at multi-year lows due to sector rotation away from animal health stocks. The combination of secular growth drivers from pet demographics, strong business fundamentals, and attractive valuation creates a compelling risk-adjusted opportunity. The manager's emphasis on current undervaluation suggests the market has oversold quality businesses in this niche healthcare segment.

Pitch Summary:
On the other side of the decision ledger during the quarter, we redeployed some of our defensive positioning by acquiring UnitedHealth on May 2. UnitedHealth is the largest health insurance company in the United States and recently faced pressure due to disappointing first-quarter results and the resignation of its CEO. Having tracked this company closely for years, I viewed the investment as a high-risk, high-reward opportunity. Although there's always a chance the stock could decline further, the expectation is that UnitedHealth will resolve its current challenges, creating significant upside. This situation is reminiscent of our previous experience with Boeing, where a turnaround took years but eventually paid off. Considering the risk-reward balance, the decision felt justified, betting on the idea that UnitedHealth is too significant to fail entirely, and even if dismantled, substantial value would remain.

BSD Analysis:
The manager initiated a position in UnitedHealth as a contrarian turnaround play following disappointing first-quarter results and CEO resignation. As the largest health insurance company in the United States, the manager views UnitedHealth as having systemic importance with a 'too big to fail' profile. The investment thesis centers on the company's ability to resolve current operational challenges and deliver significant upside once stabilized. The manager draws parallels to a successful Boeing turnaround investment, suggesting patience for multi-year recovery timelines. The high-risk, high-reward characterization acknowledges potential for further downside but emphasizes asymmetric upside potential. The manager's long-term tracking of the company provides confidence in the underlying business quality. Even in a worst-case dismantling scenario, the manager believes substantial residual value would remain, providing downside protection for the contrarian bet.

Pitch Summary:
Writing these letters is rarely easy, and this quarter is certainly no exception. In the first quarter, trimming our Microsoft position appeared to be the right decision. The news at the time suggested caution, and given the stock's considerable weighting in our portfolio, reducing the position by half seemed prudent. When the market declined sharply in April, I was relieved to have made that call. But, as fate would have it, the company reported a stunning first quarter, sending its shares soaring. Of course, we still held the stock—just not as much as before—and that weighed on our performance. Microsoft recently posted its second-quarter results, which were also impressive, accompanied by strong forward guidance. At this stage, I find myself genuinely conflicted about Microsoft, given its valuation and uncertainty about its future returns. On the one hand, I recognize the hype surrounding AI and acknowledge that excitement alone could continue to drive the stock higher. However, the company's substantial spending on data centers to support its AI initiatives is concerning. A critical, unanswered question remains whether Microsoft—and indeed the entire AI sector—will ultimately recoup these considerable investments. AI undoubtedly possesses appealing characteristics, but it also carries significant drawbacks. Moreover, differentiating among the numerous existing models can be a challenging task. Without clear differentiation, I fear AI risks becoming just another commoditized technology over time. At this juncture, I'm closely watching how earnings season unfolds before making any significant decisions, but don't be surprised if Microsoft is soon removed from our portfolio.

BSD Analysis:
The manager expresses genuine conflict about Microsoft despite the company's strong recent performance. While Microsoft delivered impressive first and second quarter results with strong forward guidance, the manager remains concerned about the sustainability of AI-driven returns. The core thesis centers on uncertainty regarding Microsoft's massive data center investments for AI initiatives and whether these capital expenditures will generate adequate returns. The manager acknowledges AI hype could continue driving the stock higher but warns of potential commoditization risks as AI models become increasingly difficult to differentiate. The position was previously reduced by half due to portfolio concentration concerns, which hurt performance when the stock rallied post-earnings. Valuation concerns and uncertainty about future AI monetization have the manager considering a complete exit. The neutral stance reflects the tension between strong fundamentals and valuation/strategic concerns about AI investment returns.

Pitch Summary:
LegalZoom ($LZ) is presented as an attractive short following a sharp share price move driven largely by enthusiasm around partnerships involving OpenAI and Perplexity. The author argues the rally has created a favorable entry point, with a price target below $6 implying >45% downside. Despite headline revenue momentum, implied full-year EBITDA has increased only marginally, suggesting deteriorating revenue quality due to higher customer acquisition costs, marketing spend, or pricing concessions. Sequential growth appears weak when adjusting for the Formation Nation acquisition, implying underlying organic growth near zero. Competitive pressures are intensifying, with OpenAI-linked alternatives (via Stripe and Intuit) and multiple startups offering lower-priced solutions. A conservative FCFE-based valuation yields equity value well below the current price, even before adjusting for execution and competitive risks.

BSD Analysis:
The online legal services industry is becoming structurally more competitive as AI lowers barriers to entry and commoditizes basic business formation workflows. LegalZoom’s historical advantage in brand and distribution is eroding as large platforms embed similar services at lower marginal cost and tighter ecosystem integration. The recent partnerships appear more sentiment-enhancing than economically transformative, with limited evidence they improve unit economics or pricing power. Revenue growth driven by acquisitions and promotional intensity risks masking stagnation in the core business. Capitalized software, stock-based compensation, and recurring tuck-in M&A meaningfully reduce true free cash flow, limiting equity value despite net cash. The key risk to the short is renewed multiple expansion driven by AI narrative rather than fundamentals. However, on normalized cash earnings, the stock appears priced for growth that exceeds realistic competitive and industry dynamics. Absent a clear inflection in organic demand or margins, downside skew remains compelling.

Actual Post Content:
I am short $LZ with PT of less than $6/sh for over 45% downside. The move today creates a decent risk/reward. Not only because many shorts covered, but also due to the magnitude of this move which appears somewhat driven by the opanAI and perplexity partnership. Because of the time sensitivity of this opportunity i will summarize at a very high level the main issues. 1. The actual implied EBITDA change for the full year is something like 165m to 169m. Which is lower than the implied revenue increase. This is likely due to higher CACs and increased marketing or price concessions. I.e the quality of revenue growth may be not very strong. 2. The company closed an acquisition in 1Q25 called formation nation. This added perhaps 12m of revs or so. That means 2Q sequential growth was negative and YoY around 1.1% 3. OpenAI also has partnerships with Stripe and Intuit for business formation. And prices appear lower than what $LZ charges. Additionally there are numerous startups, I found one that partners with Gemini. 4. I estimate real FCFE in 2026 is somewhere between 20-30m. Base case if that grows at 4% into perpetuity which would be higher than its organic growth rate and i assume an 8% required return rate, i get a NPV of 5.35 after adding back its net cash. This is all a little fuzzy and do your own due diligence especially on FCFE. I'm not super confident this is correct. It's obviously below the headline and management guidance number, but I consider capitalized software, a small amount for recurring M&A, and stock comp as real expenses. May do a follow up to narrow down valuation or trade out of the position at any moment.

URL: https://x.com/fierce__beast/status/1953868760416239909

Pitch Summary:
Although outside the second quarter timeframe, we added Zoetis to the portfolio on July 1. Zoetis specializes in veterinary pharmaceuticals, and pet owners likely recognize many of their products. The surge in pet ownership during the pandemic has expanded the company’s addressable market, as pets age and require increased medical care, driving higher healthcare costs. Zoetis offers a compelling investment case due to its stable growth trajectory, strong profit margins, and current undervaluation in a market segment that has fallen out of favor, making its shares attractively priced at levels not seen in years. :contentReference[oaicite:2]{index=2}

BSD Analysis:
Zoetis is the world’s premier animal-health company, benefiting from the durability of pet spending and livestock productivity demands. Its portfolio of vaccines, dermatology treatments, and parasiticides has pricing power and strong recurring revenue. Pet ownership and premiumization trends create a structural tailwind. Margins are consistently high due to scale and formulation expertise. Regulatory barriers in animal health are real, keeping competition rational. Zoetis is a defensive growth compounder hiding inside a niche healthcare category. When consumer staples feel stale, Zoetis feels alive.

Pitch Summary:
We redeployed some of our defensive positioning by acquiring UnitedHealth on May 2. UnitedHealth is the largest health insurance company in the United States and recently faced pressure due to disappointing first-quarter results and the resignation of its CEO. Having tracked this company closely for years, I viewed the investment as a high-risk, high-reward opportunity. Although there’s always a chance the stock could decline further, the expectation is that UnitedHealth will resolve its current challenges, creating significant upside. This situation is reminiscent of our previous experience with Boeing, where a turnaround took years but eventually paid off. Considering the risk-reward balance, the decision felt justified, betting on the idea that UnitedHealth is too significant to fail entirely, and even if dismantled, substantial value would remain. :contentReference[oaicite:1]{index=1}

BSD Analysis:
UnitedHealth continues to dominate U.S. healthcare with a dual-engine model: insurance scale plus Optum’s services, care delivery, and analytics platform. Optum is steadily shifting the mix toward higher-margin, less cyclical revenue. United’s data advantage allows it to manage risk better than peers, making underwriting more consistent across cycles. Demographics and chronic-care prevalence support long-term growth in insured lives. Regulatory overhang never disappears, but the business has navigated decades of policy shifts with barely a dent. Cash flow is massive and reliable. UNH remains the cornerstone compounder of the sector.

Pitch Summary:
In the first quarter, trimming our Microsoft position appeared to be the right decision. The news at the time suggested caution, and given the stock’s considerable weighting in our portfolio, reducing the position by half seemed prudent. When the market declined sharply in April, I was relieved to have made that call. But, as fate would have it, the company reported a stunning first quarter, sending its shares soaring. Of course, we still held the stock—just not as much as before—and that weighed on our performance. Microsoft recently posted its second-quarter results, which were also impressive, accompanied by strong forward guidance. At this stage, I find myself genuinely conflicted about Microsoft, given its valuation and uncertainty about its future returns. On the one hand, I recognize the hype surrounding AI and acknowledge that excitement alone could continue to drive the stock higher. However, the company’s substantial spending on data centers to support its AI initiatives is concerning. A critical, unanswered question remains whether Microsoft—and indeed the entire AI sector—will ultimately recoup these considerable investments. AI undoubtedly possesses appealing characteristics, but it also carries significant drawbacks. Moreover, differentiating among the numerous existing models can be a challenging task. Without clear differentiation, I fear AI risks becoming just another commoditized technology over time. At this juncture, I’m closely watching how earnings season unfolds before making any significant decisions, but don’t be surprised if Microsoft is soon removed from our portfolio. :contentReference[oaicite:0]{index=0}

BSD Analysis:
Microsoft is the enterprise AI operating system, embedding AI into Azure, Office, GitHub, and every major ecosystem foothold it owns. Azure growth remains durable as companies modernize infrastructure and build AI-driven apps. Copilot introduces a new monetization layer across Microsoft’s productivity suite, expanding ARPU rather than relying on seat growth. The company’s unmatched distribution — Windows, Office, Teams — gives it deployment speed most competitors can only dream of. Margins and cash flow remain elite despite heavy AI investment. Regulatory pressure is real but manageable. Microsoft is the cleanest, broadest exposure to enterprise software + AI in one ticker.

Pitch Summary:
The Swatch Group is trading for an unprecedented net-net valuation, just over half of tangible book value. As one of the most shorted stocks in Europe, investors are implying the company is worth more dead than alive, but we disagree. The company’s world-class brands—Harry Winston, Omega, Breguet, Blancpain, Longines, among others—have immense potential. At the May 21 ordinary general meeting, 61.9% of bearer shareholders elected Steven to the Board of Directors—a legally binding vote under Swiss law despite Hayek family resistance. We are engaging constructively with the company to resolve governance issues. Cultural change is needed as Swatch has historically rejected input from customers, wholesalers, shareholders and even managers. With shares and revenue at multi-decade lows, it is time for new approaches. Over the past year we have conducted over 100 discussions with former managers, shareholders, luxury experts and watchmakers. The luxury mechanical watch industry is in a renaissance with Gen Z 2–4x more likely to purchase mechanical watches. Swatch has lost substantial share due to outdated marketing and governance. We believe fresh perspectives and more balanced board composition can unlock substantial value as the company modernizes and leverages its iconic brands.

BSD Analysis:
UHR trades below liquidation value despite owning some of the strongest global luxury watch marques. Brand equity and long-cycle demand fundamentals remain intact, especially with demographic tailwinds from younger collectors. Governance reform is the key catalyst; majority bearer-shareholder support indicates urgency for change. Margin recovery and brand revitalization offer multiyear upside optionality, and current valuation provides a deep margin of safety.

Pitch Summary:
Las Vegas–based licensor of proprietary table games (e.g., 21+3, Lucky Ladies) with ~28 U.S. state licenses. Currently under an $85m all-cash takeout by Evolution AB at $3.20/share vs. $2.90 spot (~10% spread; ~30% annualized IRR if closed by YE’25). Shareholder approvals completed; only state gaming regulator approvals remain. Agreement allows shedding non-core licenses + revenue thresholds to streamline closing. EVO has a proven M&A track record (NetEnt, BTG) and no financing contingency. Downside if deal breaks looks modest: stock likely >$2.70–2.80 (vs pre-announcement $1.40–1.50) given $5.2m termination fee, $2.8m interest savings from refinancing, and ~$13m 2024 adj. EBITDA (~8.6x 2024; ~7.5x 2025). Board/insider buying post-announcement further signals confidence. With licensing approvals the only gating factor, odds of closing estimated >80%.

BSD Analysis:
This is a clean, high-probability small-cap merger arb. EVO is incentivized: the royalty payments to Galaxy alone justify most of the purchase price, and synergies in licensing, distribution, and digital adaptation are material. The spread persists mainly due to illiquidity (~$100k/day volume) and 5% regulatory ownership caps limiting arb flows. Downside is cushioned: refinancing improved FCF, termination fee provides ~$0.20/share, and valuation at ~$2.90 already reflects a healthier Galaxy (beat 2024/25 EBITDA forecasts). In my experience, when regulators are the sole hurdle and acquirer has deep experience in approvals, timing rather than deal risk drives spreads. The risk/reward is asymmetric: ~10% absolute upside (~30% annualized IRR) vs. ~3–7% downside. Key watch items: regulator updates, outside-date extensions into Jan 2026, and EVO commentary on pipeline. Overall, a compelling small-cap arbitrage with structural barriers keeping the spread wider than fundamentals suggest.

Pitch Summary:
Las Vegas–based licensor of proprietary table games (e.g., 21+3, Lucky Ladies) with ~28 U.S. state licenses. Currently under an $85m all-cash takeout by Evolution AB at $3.20/share vs. $2.90 spot (~10% spread; ~30% annualized IRR if closed by YE’25). Shareholder approvals completed; only state gaming regulator approvals remain. Agreement allows shedding non-core licenses + revenue thresholds to streamline closing. EVO has a proven M&A track record (NetEnt, BTG) and no financing contingency. Downside if deal breaks looks modest: stock likely >$2.70–2.80 (vs pre-announcement $1.40–1.50) given $5.2m termination fee, $2.8m interest savings from refinancing, and ~$13m 2024 adj. EBITDA (~8.6x 2024; ~7.5x 2025). Board/insider buying post-announcement further signals confidence. With licensing approvals the only gating factor, odds of closing estimated >80%.

BSD Analysis:
This is a clean, high-probability small-cap merger arb. EVO is incentivized: the royalty payments to Galaxy alone justify most of the purchase price, and synergies in licensing, distribution, and digital adaptation are material. The spread persists mainly due to illiquidity (~$100k/day volume) and 5% regulatory ownership caps limiting arb flows. Downside is cushioned: refinancing improved FCF, termination fee provides ~$0.20/share, and valuation at ~$2.90 already reflects a healthier Galaxy (beat 2024/25 EBITDA forecasts). In my experience, when regulators are the sole hurdle and acquirer has deep experience in approvals, timing rather than deal risk drives spreads. The risk/reward is asymmetric: ~10% absolute upside (~30% annualized IRR) vs. ~3–7% downside. Key watch items: regulator updates, outside-date extensions into Jan 2026, and EVO commentary on pipeline. Overall, a compelling small-cap arbitrage with structural barriers keeping the spread wider than fundamentals suggest.

Pitch Summary:
JOE owns approximately 167,000 acres in the Florida Panhandle. It has been widely known that JOE traded for a tiny fraction of its liquidation value for years, but without a catalyst, it was always perceived to be "dead money." Over the past few years, the population of the Panhandle has hit a critical mass where the Panhandle now has a center of gravity that is attracting people who want to live in one of the prettiest places in the country, with zero state income taxes and few of the problems of large cities. The oddity of the current disdain for so-called "value investments" is that many of them are growing quite fast. I believe that JOE may grow revenue at a rapid rate for the foreseeable future, with earnings growing at a much faster clip. Meanwhile, I believe the shares trade at an attractive multiple on Adjusted Funds from Operations (AFFO), while substantial asset value is tossed in for free. Besides the valuation, growth, and high Return on Invested Capital (ROIC) of the business, why else do I like JOE? For starters, land tends to appreciate rapidly during periods of high inflation. More importantly, I believe we are witnessing a massive population migration as people with means choose to flee big cities for somewhere peaceful. I suspect that every convulsion of urban chaos and/or tax-the-rich scheming will launch JOE shares higher, and it will ultimately be seen as the way to "play" the stream of very wealthy refugees fleeing for somewhere better.

BSD Analysis:
The manager presents a compelling bull case for St. Joe Company based on a demographic inflection point in the Florida Panhandle. The thesis centers on the region reaching critical mass population density that creates a self-reinforcing cycle of attracting affluent residents seeking low taxes and quality of life. The manager highlights the paradox of value investing where JOE appears to be growing rapidly despite trading at attractive valuations on AFFO metrics. The investment benefits from multiple tailwinds including inflation hedge characteristics of land ownership, urban-to-rural migration trends, and tax policy advantages. The manager views JOE as a pure play on wealthy demographic migration patterns, with each episode of urban unrest or tax increases serving as a catalyst. The position represents a contrarian value play with growth characteristics, trading below liquidation value while generating strong returns on invested capital.

Pitch Summary:
NZME (NZM.AX) is positioned as an activist-driven value opportunity, trading at a deep discount to underlying asset value despite dominant market positions across print, radio, and digital classifieds. The company controls ~50% of New Zealand’s newspaper market via the New Zealand Herald, ~40% of radio, and owns OneRoof, a top-tier real estate classifieds platform. Longstanding operational underperformance prompted a strategic review of OneRoof earlier this year, followed by activist investor Jim Grenon building a 13.5% stake and launching a proxy challenge. A subsequent settlement delivered Grenon a board seat and installed a new chairman aligned with change. A sum-of-the-parts analysis implies fair value of A$1.50–1.66/share versus ~A$1.04 currently, while investors earn an 8–9% dividend yield awaiting monetization.

BSD Analysis:
Legacy media is structurally challenged, but NZME’s asset mix is mischaracterized by the market, with classifieds and audio providing materially different economics than print alone. OneRoof sits in an attractive digital classifieds segment where network effects and local brand strength support valuations well above those implied in the stock. The company’s competitive position in New Zealand is unusually strong, benefiting from market concentration that limits disruptive entry. Activist involvement meaningfully alters governance risk, increasing the probability of rational capital allocation and asset monetization. The key execution risk lies in separating value realization from declining legacy cash flows without destroying optionality. Secular pressure on print remains a headwind, but it is already more than reflected in valuation. Dividend yield provides downside support while the strategic review progresses. If OneRoof is monetized at even conservative peer multiples, equity upside is substantial relative to current pricing.

Actual Post Content:
Activist involvement over at $NZM.AX looks intriguing, with potential upside of around 50%+ NZM is a major force in New Zealand’s media landscape. The company owns about 50% of the newspaper market (anchored by The New Zealand Herald), holds 40% share in the radio market, and owns OneRoof, the country’s 2nd/3rd largest real estate classifieds site. The company has been poorly managed for years, with the stock trading at a steep discount to its underlying asset value. Back in February, NZME launched a strategic review of its classifieds business, OneRoof. Shortly after, billionaire activist Jim Grenon quickly built a 13.5% stake and initiated a proxy fight to replace the board. In May, the parties reached a settlement agreement, resulting in Grenon securing a board seat, along with the appointment of a new chairman approved by him. This leadership shift, combined with the ongoing strategic review, makes it increasingly likely that we’ll see a monetisation of the OneRoof business. SOTP valuation breaks down as follows: - 6x EBITDA for the profitable, dominant publishing business - 4x EBITDA for the Audio segment (in line with comps) - 3x sales for OneRoof’s digital business - 1x sales for OneRoof's print magazine business The OneRoof valuation appears especially conservative, given where most classifieds businesses trade. Grenon’s assumptions value OneRoof at 5x sales for its digital operations and 1x for print. Overall, fair value is somewhere between A$1.50 and A$1.66/share, compared to the current share price of A$1.04. While we wait for a resolution, investors can collect an 8–9% dividend yield.

URL: https://x.com/investspecial/status/1953399660942446697

Pitch Summary:
Novo Nordisk ($NVO) is framed as an attractive long not because of short-term GLP-1 hype, but due to its century-long focus on diabetes and decades of leadership in complex protein chemistry. The pitch emphasizes Novo’s culture of transparency, ethical operating model, and unusually shareholder-aligned governance, with ~28% ownership by the Novo Nordisk Foundation reinvesting dividends into scientific research. GLP-1 drugs are seen as a continuation of Novo’s historical dominance in insulin, where innovation—not patents alone—has sustained leadership despite pricing pressure. While government pricing constraints are inevitable, they are portrayed as a feature of the business model rather than a flaw. Compared with Eli Lilly trading at much higher multiples, Novo’s 12–14× earnings valuation is viewed as compelling. The market is framed as large, durable, and non–winner-take-all.

BSD Analysis:
The metabolic disease pharma market is structurally attractive, driven by rising global obesity and diabetes prevalence, with high scientific and regulatory barriers limiting credible competition. Novo Nordisk’s competitive position is rooted in deep protein chemistry expertise, manufacturing scale, and decades-long clinician trust—advantages that are difficult to replicate even for well-capitalized peers. Secular growth in GLP-1 demand extends beyond obesity into cardiovascular and metabolic indications, supporting long-duration revenue streams. Governance structure via the foundation promotes strategic patience and R&D reinvestment, reducing risk of short-termism. Pricing pressure from payors is inevitable, but history shows innovation cycles—not price hikes—drive economic returns in this category. Valuation at a mid-teens earnings multiple appears to discount patent cliffs while underappreciating Novo’s demonstrated ability to refresh its portfolio. Key risks include competitive innovation velocity and reimbursement tightening, not demand durability. On normalized earnings power, Novo offers asymmetric value relative to higher-multiple peers in a structurally expanding market.

Actual Post Content:
$NVO is probably a no-brainer investment. And it’s not why everyone thinks. 1. 100 year old company only focused on diabetes and GLP-1 for 25 years. the most transparent ethical pharma co ever 2. ⁠GLP is Protein chemistry which is notoriously complex and r&d needs are high This is trading at 12-14 times earnings. I can’t predict the next wonder drug. Neither can I tell anything from phase-3 trail results. But I can tell this - NOVO is transparent to a fault. No window dressing in their annual reports. They have a website only to display all their trail results for everyone to access. There is zero obligation for this company to maintain such a site. It has documentation of their trial design and results. $NVO Novo Nordisk way is a set of principles basis which they operate where one of the founding principles is to make money for shareholders which will eventually help them to stay in business so they can do good for their patients. 28% of Novo nordisk is owned by a foundation which oversees stability of the company. The dividends is reinvested into other startups to promote scientific research. The incentives are aligned to stay durable. Protein chemistry isn’t easy. If I am worried about GLP patent expiring, I should also be worried about insulin patents. Insulin was discovered in 1922. If Novo can dominate insulin market with innovation, perhaps they can do same with GLP-1. There is inherent price pressure with insulin and probably with GLP-1. This comes in the form of Medicare issues, govt issues. It’s not a bug but a feature. Pricing power lies only in new drugs. It was the case with insulin too. That’s the business if you want to buy into it. It doesn’t matter who maintains the lead between $LLY vs $NVO. Both are fantastic companies and likely to do well. Obesity and Diabetes are huge problems. This is not a winner take all market. Except $LLY trades at 60 times earnings That’s the investment case. Maybe this will become a Visa-Mastercard type duopoly. Maybe. But I am getting ahead of myself. Right now, the returns from $NVO looks good given its price.

URL: https://x.com/earningsb4hugs/status/1953435434211541006

Pitch Summary:
On the one hand, people pay managers to diversify across large cap, small cap, international, emerging markets, bonds, and alternatives. They pay a fee on all that and get maybe a 1% or 2% dividend yield. On the other hand, you can be paid to get all of that in Alliance Bernstein, which is used in some income-oriented portfolios. As a unit holder, rather than being a client, you’re a partial owner of this respected publicly traded asset manager. Meaning that instead of being a fee payer, you’re a fee collector.
As an LP, the company pays out its earnings, and the recent distribution, which varies with operating profits, yields about 8%. Unlike most active managers, the company has been a recipient of net asset inflows for several years. Between such ordinary external growth, if it continues, and long-term appreciation of the portfolio, achieving an extra 2% is a modest hurdle. The company is also majority owned by Equitable Holdings, which in April increased its interest from 51% to 69% and also invests in Alliance Bernstein funds.
So, own the manager, take some of the fees, start off 80% of the way toward a 10% return. It’s a different return model than buying a portfolio of ETF asset classes, or than a “dividend aristocrats” ETF that might have a 3%-ish yield.

BSD Analysis:
AllianceBernstein is a high-quality, asset-light investment manager whose stock is poised for a major re-rating driven by a massive, high-impact real estate catalyst and a powerful fee-based model. The core thesis is the accelerating momentum of its $50 billion Wealth Management business and its strategic shift to its new Nashville headquarters. The move to the lower-cost Nashville hub is expected to deliver substantial, structural margin expansion and drive operational efficiency. Crucially, the company's low P/E multiple and high dividend yield (∼7%) fundamentally misprice the stability of its $725+ billion Assets Under Management (AUM) and the predictable, high-margin fee income. This is a defensive compounder in the financial sector, offering a high, visible yield combined with a major, multi-year catalyst from its strategic real estate transition.

Pitch Summary:
Japan Elevator Service Holdings (JES) is the largest independent elevator and escalator maintenance and repair service provider in Japan, with a 10% market share. Typical clients are building owners and real estate maintenance and management companies legally required to have annual inspections on their elevators and escalators. They generally enter contracts that include an annual inspection, monthly checkup, and repairs when necessary. This arrangement provides a recurring and stable revenue stream. There are over 900,000 elevators and escalators under such contracts in Japan, and the number has expanded about 3% annually during the past decade.
When Chairman, CEO, and President Katsushi Ishida founded JES in 1994, the elevator and escalator service market was over 95% dominated by five manufacturers: Toshiba, Mitsubishi, Hitachi, Fujitec, and Japan Otis. The remaining 5% was shared by hundreds of independent service providers; manufacturers competed for new elevator and escalator sales and installation.
However, in this business, once one receives installation orders, the maintenance service contracts naturally accrue the manufacturer, as it already has full understanding of the models; most importantly, it can easily set aside adequate replacement parts. Moreover, manufacturers have no incentive to take maintenance contracts for competitors’ models, just like Toyota dealers will not actively seek maintenance work for Ford automobiles. As a result, the service price is set high enough to recoup the low profit, if any, resulting from the price competition around installment.
Maintenance and repair services, even for a standard model, require thousands of parts. Covering available models of major brands with guaranteed timely service means having an inventory of more than 150,000 parts. The control panel is the most crucial, in that genuine manufacturers’ control panels have unparalleled performance and durability compared to generic versions. The inability to secure these often hinders independent service providers from providing high-quality services on par with manufacturers, and is a hurdle in expanding service networks.
Another obstacle is the ability to hire qualified inspectors. In Japan, only inspectors with a national qualification—which requires certain electrical and electronic engineering degrees and years of on-the-job experience—can conduct annual inspections. Independent operators need an appropriate number of such inspectors to sufficiently cover their customer base.
An Owner-Operator’s Entrepreneurial Counter-Perspective
At this point in the description of this industry, one might justifiably conclude that this slow-growth sector offers hardly any business opportunity for independent operators, other than competing in a zero-sum game to take small market share
However, in the early 1990s, Chairman Ishida—a licensed elevator inspector himself—saw a business opportunity in an industry whose high barriers to entry could actually become a competitive benefit upon overcoming them and achieving sufficient scale. Having worked for a building maintenance company, and for an independent elevator maintenance service provider, Chairman Ishida was convinced a well-run business could generate double-digit operating margins, even at half the price of the leading manufacturers. To seize market share, he was determined to build a company that would provide services at their level or better.
So, in 1994, at age 28, Chairman Ishida founded the company alone—with no funds, no partners, and no employees. Nevertheless, he was determined to provide the highest-quality professional service from day one. When visiting potential customers as a salesperson, he would change into a business suit, then switch back to workwear to do maintenance and inspections. He reviewed inspection reports directly with customers before and after; this was not common among typical industry engineers, who would focus on the inspection work itself and delegate customer communication to a sales department. He often slept at the office to respond to emergency calls.
As the number of contracts grew, he needed to hire and train more employees, and he needed to procure enough parts for timely service. For the first three years, JES was literally a hand-to-mouth operation, and Chairman Ishida had to fund the running cost with short-term loans just to meet immediate cash needs. Within ten years, though, the number of maintenance units reached 5,000. At this point, he managed to hire a full management team to run the business.
In 2007, JES hit a milestone as an independent service provider: matching the service capabilities of the leading manufacturers upon developing a 24-hour remote monitoring and controlling service. This technology enabled the company to monitor elevator and escalator operating status 24 hours a day, seven days a week—and to detect small irregularities, which enabled targeted preventive repair and parts replacement to reduce the incidence of malfunctions and breakdowns. Until that moment, this type of service had only been provided by the leading manufacturers, as it required access to the control panel, and required resolving their unique data transmission and protocols. Toward this goal, Chairman Ishida had hired system engineers to research and develop a remote monitoring system compatible with various models of elevators and escalators, and even obtained a patent on the technology.
That same year, JES established an original engineer-training program and internal qualification system called “Step 24.” Even before this program, Chairman Ishida undertook a training program that systematized the skills and experience of top engineers, and collected and researched maintenance information and data for various models. Through what became a 24-lecture series and on-the-job training, new employees could acquire the skills and knowledge needed to attain a national inspection license in one year. Moreover, the program trained engineers to individually conduct full maintenance work for several models, enabling the company to provide equivalent quality services to the leading manufacturers.
Critically, and unlike these competitors providing maintenance only to their brands, this meant JES was now able to leverage its operation as its engineers expanded their capabilities and productivities to include more elevators in a given coverage area. Being an engineer himself, Chairman Ishida respected engineers and always knew they were the cornerstone of the operation (later, in 2019, he set up a “Engineer Meister Program” with five accreditation levels to incentivize engineers with the best skill sets to maintain the service quality).
At the same time, Chairman Ishida sought to publicly list JES to increase its credibility and transparency in furtherance of expansion. It took just over a decade to prepare for the listing; the focus was on human resource development, enhancing technology and capability, and securing genuine parts. JES went public in 2017.
The same year, JES completed construction of an R&D test tower and innovation center with ten elevators to examine control systems and motors. It conducted thousands of tests—allowing further improvement on maintenance and repair offerings and operational efficiency—and developed new services for the market.
In 2018, the company developed its next-generation control system, Quick Renewal, which was compatible with the general models of all the equipment manufacturers. Typically, elevators’ stated useful life is 20 to 25 years; in practice they operate 25 to 30 years. At that point, they need a full renewal, which entails replacing the control system, motors and all electric systems—and requires about one full week of downtime. Quick Renewal necessitates just a half-day of down time, and at half the price.
Illustratively, a building operating for 60 years usually requires three full equipment renewals. With Quick Renewal, three controller system replacements are needed, but only two motor replacements, leading to a significant reduction of customers’ downtime and maintenance cost. For JES, Quick Renewal was an important offering to induce customers to switch maintenance companies and add to its service contracts portfolio.
The growth in the number of maintenance units accelerated following the company’s IPO and introduction of new services. JES’s market share reached 10% in 2023; in 2024 it added over 13,000 units, taking another 1.3% of market share.
It is important to recognize this “the only one” position Chairman Ishida has built since founding JES. Its maintenance units’ failure rate is as low as 1%, equivalent to that of leading elevator and escalator manufacturers, and one-fifth that of the independent service providers.
The JES offering price remains about 30% to 40% below that of the leading manufacturers. For independent service providers, it is not easy to set a competitive price without operational scale, since they need to hire licensed engineers and procure parts, essentially where JES was in its early years.
As a result, the company is taking market share both from the manufacturers and the smaller independent providers. In the recent inflationary environment, those competitors have been raising their prices, while JES continues to focus on advancing its market share, thereby accumulating more maintenance contracts.
The company is also expanding its coverage area, entering second- and third-tier cities and acquiring smaller independent service providers, which usually start from a loss-making position until the branch achieves sufficient scale.
Even with the advancements to date, having improved the operating margin from 12.7% to 17.7% during the last five years, management appears confident about reaching 20% in the coming two years. In the longer term, once the growth investment spending decelerates, management sees a 30% margin as a natural, sustainable profitability level.
Most recently, inquiries from real estate management companies are rising as they try to lower elevator and escalator maintenance costs as part of broader building maintenance cost reductions. JES also established strategic tie-ups with banks that are financing new real estate development or re-development as another avenue to secure new maintenance contracts.
There is an opportunity for even more expansion domestically. In other developed markets outside Japan where major maintenance providers compete, independent service providers typically represent a 50% market share. That should be possible in Japan, too. For the near term, JES is aiming to take at least a 30% market share, approximately three times its current level.

BSD Analysis:
Japan Elevator Service Holdings is a high-growth, niche monopoly in the critical, non-cyclical market of elevator maintenance and repair, offering a defensive compounder with a clear path to scale. The core moat is its focus on third-party, non-OEM maintenance, which is structurally cheaper and provides a vital, high-margin, recurring revenue stream. The company is executing a clear strategy of aggressive regional expansion across Japan, targeting the vast base of elevators installed by its larger competitors. Crucially, its revenue is entirely non-discretionary, guaranteed by the mandatory safety regulations that require regular maintenance, ensuring stability regardless of the economic cycle. The stock is trading at a premium justified by its consistent double-digit revenue growth and the clear, massive market opportunity of converting existing maintenance contracts to its superior service model.

Pitch Summary:
JOE owns approximately 167,000 acres in the Florida Panhandle. It has been widely known that JOE traded for a tiny fraction of its liquidation value for years, but without a catalyst, it was always perceived to be "dead money." Over the past few years, the population of the Panhandle has hit a critical mass where the Panhandle now has a center of gravity that is attracting people who want to live in one of the prettiest places in the country, with zero state income taxes and few of the problems of large cities. The oddity of the current disdain for so-called "value investments" is that many of them are growing quite fast. I believe that JOE may grow revenue at a rapid rate for the foreseeable future, with earnings growing at a much faster clip. Meanwhile, I believe the shares trade at an attractive multiple on Adjusted Funds from Operations (AFFO), while substantial asset value is tossed in for free. Besides the valuation, growth, and high Return on Invested Capital (ROIC) of the business, why else do I like JOE? For starters, land tends to appreciate rapidly during periods of high inflation. More importantly, I believe we are witnessing a massive population migration as people with means choose to flee big cities for somewhere peaceful. I suspect that every convulsion of urban chaos and/or tax-the-rich scheming will launch JOE shares higher, and it will ultimately be seen as the way to "play" the stream of very wealthy refugees fleeing for somewhere better.

BSD Analysis:
The St. Joe Company is a unique, high-quality real estate developer that functions as a leveraged bet on the long-term, compounding value of its massive land holdings in the Florida Panhandle. The core moat is its ownership of 170,000 acres in one of the fastest-growing regions of the US, providing a multi-decade runway for monetizing land and commercial development. The company's strategy is to create fully integrated Master Planned Communities (MPCs), which drive sticky, recurring revenue from long-term commercial leases and a high-margin hospitality segment. St. Joe is a conviction bet on the intrinsic value of land, offering a pure, long-duration growth story in a market with favorable demographic tailwinds.

Pitch Summary:
Vail endured a difficult ski season compounded by a poorly managed PR crisis related to the Park City Ski Patrol strike. The managers did not originally purchase the stock expecting a turnaround, but that’s what it became. Their exit reflected opportunity cost and a desire to step back while the company sorts through reputational and operational issues. With Rob Katz returning as CEO—the architect of the multi-mountain pass—they are monitoring but not yet convinced.

BSD Analysis:
Vail Resorts is an oligopolist in the destination mountain resort market whose financial dominance is structurally secured by its Epic Pass subscription model. The core moat is its massive scale (41 resorts across four continents) and the pre-season revenue predictability granted by the non-refundable, fixed-price pass. The entire thesis is a high-quality annuity: the Epic Pass locks in customer loyalty, eliminates the seasonality risk of single-day tickets, and provides superior operating leverage. While the stock faces short-term volatility from unpredictable weather patterns, its long-term financial stability and superior pricing power in a high-demand, experiential leisure market make it a compelling compounder.